nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0405	0.0452	CcSEcCtD
Terbinafine—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0358	0.0399	CcSEcCtD
Terbinafine—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0304	0.0339	CcSEcCtD
Terbinafine—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.028	0.0313	CcSEcCtD
Terbinafine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0278	0.0311	CcSEcCtD
Terbinafine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0252	0.0282	CcSEcCtD
Terbinafine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0233	0.026	CcSEcCtD
Terbinafine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0227	CcSEcCtD
Terbinafine—CYP2C19—urine—nephrolithiasis	0.0197	0.189	CbGeAlD
Terbinafine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0196	0.0219	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0211	CcSEcCtD
Terbinafine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0211	CcSEcCtD
Terbinafine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0205	CcSEcCtD
Terbinafine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0182	CcSEcCtD
Terbinafine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0161	0.018	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0161	0.018	CcSEcCtD
Terbinafine—CYP1A2—urine—nephrolithiasis	0.0161	0.154	CbGeAlD
Terbinafine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0177	CcSEcCtD
Terbinafine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0172	CcSEcCtD
Terbinafine—CYP2C9—urine—nephrolithiasis	0.0152	0.147	CbGeAlD
Terbinafine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0169	CcSEcCtD
Terbinafine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0161	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0144	0.016	CcSEcCtD
Terbinafine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0157	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0152	CcSEcCtD
Terbinafine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0134	0.015	CcSEcCtD
Terbinafine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0144	CcSEcCtD
Terbinafine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0138	CcSEcCtD
Terbinafine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0137	CcSEcCtD
Terbinafine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0133	CcSEcCtD
Terbinafine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0131	CcSEcCtD
Terbinafine—CYP3A4—urine—nephrolithiasis	0.0116	0.112	CbGeAlD
Terbinafine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0129	CcSEcCtD
Terbinafine—CYP2D6—urine—nephrolithiasis	0.0114	0.11	CbGeAlD
Terbinafine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0122	CcSEcCtD
Terbinafine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0108	0.012	CcSEcCtD
Terbinafine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0118	CcSEcCtD
Terbinafine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0118	CcSEcCtD
Terbinafine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0116	CcSEcCtD
Terbinafine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0113	CcSEcCtD
Terbinafine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00999	0.0112	CcSEcCtD
Terbinafine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00995	0.0111	CcSEcCtD
Terbinafine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00984	0.011	CcSEcCtD
Terbinafine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00971	0.0108	CcSEcCtD
Terbinafine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0108	CcSEcCtD
Terbinafine—Cough—Hydrochlorothiazide—nephrolithiasis	0.0094	0.0105	CcSEcCtD
Terbinafine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0102	CcSEcCtD
Terbinafine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0102	CcSEcCtD
Terbinafine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0102	CcSEcCtD
Terbinafine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00914	0.0102	CcSEcCtD
Terbinafine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00906	0.0101	CcSEcCtD
Terbinafine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00897	0.01	CcSEcCtD
Terbinafine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00886	0.00989	CcSEcCtD
Terbinafine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00879	0.00981	CcSEcCtD
Terbinafine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0086	0.0096	CcSEcCtD
Terbinafine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00935	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00801	0.00894	CcSEcCtD
Terbinafine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00789	0.00881	CcSEcCtD
Terbinafine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00863	CcSEcCtD
Terbinafine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00853	CcSEcCtD
Terbinafine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00846	CcSEcCtD
Terbinafine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00752	0.00839	CcSEcCtD
Terbinafine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00724	0.00808	CcSEcCtD
Terbinafine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00802	CcSEcCtD
Terbinafine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00698	0.00779	CcSEcCtD
Terbinafine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00775	CcSEcCtD
Terbinafine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00775	CcSEcCtD
Terbinafine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00723	CcSEcCtD
Terbinafine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00704	CcSEcCtD
Terbinafine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00694	CcSEcCtD
Terbinafine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00671	CcSEcCtD
Terbinafine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00649	CcSEcCtD
Terbinafine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00624	CcSEcCtD
Terbinafine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00618	CcSEcCtD
Terbinafine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00618	CcSEcCtD
Terbinafine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00614	CcSEcCtD
Terbinafine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00583	CcSEcCtD
Terbinafine—CYP2C8—renal system—nephrolithiasis	0.0042	0.0404	CbGeAlD
Terbinafine—CYP2C8—kidney—nephrolithiasis	0.00406	0.039	CbGeAlD
Terbinafine—CYP1A2—renal system—nephrolithiasis	0.00393	0.0378	CbGeAlD
Terbinafine—PTGS1—renal system—nephrolithiasis	0.0034	0.0327	CbGeAlD
Terbinafine—PTGS1—kidney—nephrolithiasis	0.00329	0.0317	CbGeAlD
Terbinafine—CYP3A4—renal system—nephrolithiasis	0.00284	0.0273	CbGeAlD
Terbinafine—CYP2D6—renal system—nephrolithiasis	0.0028	0.0269	CbGeAlD
Terbinafine—CYP3A4—kidney—nephrolithiasis	0.00275	0.0264	CbGeAlD
Terbinafine—CYP2D6—kidney—nephrolithiasis	0.0027	0.026	CbGeAlD
